TERRY WHITE CHEMISTS OXYCODONE MR oxycodone hydrochloride 10mg modified release tablets blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

oxycodone hydrochloride, Quantity: 10 mg

Commercializzato da:

Arrotex Pharmaceuticals Pty Ltd

INN (Nome Internazionale):

oxycodone hydrochloride

Forma farmaceutica:

Tablet, modified release

Composizione:

Excipient Ingredients: hypromellose; lactose; ethylcellulose; colloidal anhydrous silica; magnesium stearate; hyprolose; macrogol 8000; titanium dioxide

Via di somministrazione:

Oral

Confezione:

28, 20, 60

Tipo di ricetta:

(S8) Controlled Drug

Indicazioni terapeutiche:

TERRY WHITE CHEMISTS OXYCODONE MR modified release tablets are indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive; and ? requires daily, continuous, long-term treatment. TERRY WHITE CHEMISTS OXYCODONE MR is not indicated for the use in chronic non-cancer pain other than in exceptional circumstances. TERRY WHITE CHEMISTS OXYCODONE MR is not indicated as an as-needed (PRN) analgesia.

Dettagli prodotto:

Visual Identification: White, round, biconvex film-coated tablet, engraved 'APO' on one side, 'OCD' over '10' on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2014-11-21